Bottom line
CURE vs TSLS: the short answer
CURE (Direxion Daily Healthcare Bull 3X ETF) and TSLS (Direxion Daily TSLA Bear 1X ETF) are both etfs.
But CURE is far broader, holding 67 positions to 9 for TSLS, so beyond the top names it adds exposure TSLS doesn't have.
CURE is cheaper at 0.94% vs 0.95% — a difference of $1.00 a year per $10,000 invested.
Over one year, CURE returned +22.9% vs −34.8% for TSLS.
Updated Nov 19, 2026
CURE vs TSLS side by side
| CURE | TSLS | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | Direxion | Direxion |
| Category | Leveraged & Inverse | Leveraged & Inverse |
| Expense ratio | 0.94% | 0.95% |
| Annual cost per $10k | $94 | $95 |
| 10-yr cost on $10k (prospectus) | $1,155 | $1,166 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +22.9% | −34.8% |
| 5-yr return (annualized) | +8.6% | — |
| 10-yr return (annualized) | +13.6% | — |
| Best quarter | +46.9% | +40.3% |
| Worst quarter | −45.8% | −46.5% |
| Net assets (fund) | $171.7M | $80.8M |
| Number of holdings | 67 | 9 |
| Portfolio turnover | 1% | % |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | CURE | TSLS | Difference |
|---|---|---|---|
| 2025 | +22.9% | −34.8% | +57.7% |
| 2024 | −8.5% | −55.7% | +47.2% |
| 2023 | −9.8% | −60.2% | +50.4% |
Source: Fund prospectus bar charts
Holdings overlap
6 of CURE's top 25 holdings also appear in TSLS's top 9.
| Holding | CURE | TSLS |
|---|---|---|
| Dreyfus | 18.79% | 71.51% |
| N/a | 8.28% | -0.18% |
| Goldman Sachs Liq Es Fd A | 8.19% | 11.43% |
| Goldman Financial | 7.51% | 12.03% |
| N/a | 3.34% | -0.18% |
| N/a | 1.12% | -0.18% |
Source: SEC Form N-PORT
CURE top 10
- Dreyfus — 18.79%
- Eli Lilly & Company — 10.41%
- N/a — 8.28%
- Goldman Sachs Liq Es Fd A — 8.19%
- Goldman Financial — 7.51%
- Johnson & Johnson — 7.07%
- Abbvie Inc — 5.08%
- Unitedhealth Group Inc — 4.31%
- Merck & Company Inc — 3.68%
- N/a — 3.34%
TSLS top 10
- Dreyfus — 71.51%
- N/a — 13.30%
- Goldman Financial — 12.03%
- Goldman Sachs Liq Es Fd A — 11.43%
- Dreyfus — 9.58%
- N/a — 2.60%
- N/a — 2.55%
- N/a — -0.18%
- N/a — -0.18%
FAQ
What is the difference between CURE and TSLS?
Which is cheaper, CURE or TSLS?
Should I own both CURE and TSLS?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.